GxMed Nordic ApS: Financial statements 2018
CVR: 37089842
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
GxMed Nordic ApS (CVR 37089842) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,632,509 and a net result of DKK -442,136 compared with DKK -1,106,996 the year before. Equity in the 2018 report amounted to DKK 421,330. The solvency ratio was 3.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,632,509
- Profit/Loss
- DKK -442,136
- Equity
- DKK 421,330
- Total Assets
- DKK 12,940,736
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
GxMed Nordic ApS has published its annual report for 2017. Gross profit came to DKK -505,914, and the net result was DKK -1,106,996.
As of April 16, 2018, Hans Henrik Raith has left the board of directors of GxMed Nordic ApS.
On April 16, 2018, the company changed its name from GxMed Nordic IVS to GxMed Nordic ApS.
As of March 23, 2018, Michael Winstrøm has left the board of directors of GxMed Nordic ApS.
About GxMed Nordic ApS
GxMed Nordic ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2015. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GxMed Nordic IVS. The company is owned by HHR HOLDING A/S. The company has 1 employee (2020). In 2022, the company reported a gross profit of DKK -144,834 and a net result of DKK -117,961 compared with DKK 1,056,263 the year before. Equity in the 2022 report amounted to DKK 1,488,024.